Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""IDIOPATHIC pulmonary fibrosis"" wg kryterium: Temat


Tytuł :
SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis.
Autorzy :
Wendisch D; Charité - Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany.
Dietrich O; Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz-Center for Infection Research (HZI), Würzburg, Germany.
Mari T; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Proteome Dynamics, Berlin, Germany.
von Stillfried S; Institute of Pathology, RWTH Aachen University Hospital, Aachen, Germany.
Ibarra IL; Institute of Computational Biology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Mittermaier M; Charité - Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany; Berlin Institute of Health (BIH), Berlin, Germany.
Mache C; Unit 17 Influenza and other Respiratory Viruses, Robert Koch Institute, Berlin, Germany.
Chua RL; Center for Digital Health, Berlin Institute of Health (BIH) and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Knoll R; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Germany.
Timm S; Core Facility Electron Microscopy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Brumhard S; Charité - Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany.
Krammer T; Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz-Center for Infection Research (HZI), Würzburg, Germany.
Zauber H; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Proteome Dynamics, Berlin, Germany.
Hiller AL; Charité - Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany.
Pascual-Reguant A; Charité - Universitätsmedizin Berlin, Department of Rheumatology and Clinical Immunology, Charité; Deutsches Rheumaforschungszentrum, Immunodynamics, a Leibniz Institute, Berlin, Germany.
Mothes R; Deutsches Rheumaforschungszentrum, Immunodynamics, a Leibniz Institute, Berlin, Germany; Charité - Universitätsmedizin Berlin, Department of Neuropathology, Berlin, Germany.
Bülow RD; Institute of Pathology, RWTH Aachen University Hospital, Aachen, Germany.
Schulze J; Unit 17 Influenza and other Respiratory Viruses, Robert Koch Institute, Berlin, Germany.
Leipold AM; Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz-Center for Infection Research (HZI), Würzburg, Germany.
Djudjaj S; Institute of Pathology, RWTH Aachen University Hospital, Aachen, Germany.
Erhard F; Institute for Virology and Immunobiology, Julius-Maximilians-University Würzburg, Würzburg, Germany.
Geffers R; Genome Analytics, Helmholtz-Center for Infection Research (HZI), Braunschweig, Germany.
Pott F; Berlin Institute of Health (BIH), Berlin, Germany; Charité - Universitätsmedizin Berlin, Institute of Virology, Charité Universitätsmedizin Berlin, Berlin, Germany.
Kazmierski J; Berlin Institute of Health (BIH), Berlin, Germany; Charité - Universitätsmedizin Berlin, Institute of Virology, Charité Universitätsmedizin Berlin, Berlin, Germany.
Radke J; Berlin Institute of Health (BIH), Berlin, Germany; Charité - Universitätsmedizin Berlin, Department of Neuropathology, Berlin, Germany.
Pergantis P; Charité - Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany.
Baßler K; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Germany.
Conrad C; Charité - Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany.
Aschenbrenner AC; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Germany; PRECISE Platform for Genomics and Epigenomics at Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), and University of Bonn, Bonn, Germany; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
Sawitzki B; Charité, Universitätsmedizin Berlin, Institute of Medical Immunology, Charité, Universitätsmedizin Berlin, Berlin, Germany.
Landthaler M; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Wyler E; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Horst D; Charité - Universitätsmedizin Berlin, Institute of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Hippenstiel S; Charité - Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany; German Center for Lung Research (DZL), Germany.
Hocke A; Charité - Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany; German Center for Lung Research (DZL), Germany.
Heppner FL; Charité - Universitätsmedizin Berlin, Department of Neuropathology, Berlin, Germany; Cluster of Excellence, NeuroCure, Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany.
Uhrig A; Charité - Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany.
Garcia C; Charité - Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany.
Machleidt F; Charité - Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany.
Herold S; German Center for Lung Research (DZL), Germany; Division of Infectious Diseases, Pulmonary and Critical Care Medicine, Department of Internal Medicine II, Universities of Giessen and Marburg Lung Center, Giessen, Germany; Institute of Lung Health (ILH), Giessen, Germany.
Elezkurtaj S; Charité - Universitätsmedizin Berlin, Institute of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Thibeault C; Charité - Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany.
Witzenrath M; Charité - Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany; German Center for Lung Research (DZL), Germany.
Cochain C; Comprehensive Heart Failure Center Wuerzburg, University Hospital Würzburg, Germany; Institute of Experimental Biomedicine, University Hospital Würzburg, Würzburg, Germany.
Suttorp N; Charité - Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany; German Center for Lung Research (DZL), Germany.
Drosten C; Charité - Universitätsmedizin Berlin, Institute of Virology, Charité Universitätsmedizin Berlin, Berlin, Germany; German Center for Infection Research (DZIF), Braunschweig, Germany.
Goffinet C; Berlin Institute of Health (BIH), Berlin, Germany; Charité - Universitätsmedizin Berlin, Institute of Virology, Charité Universitätsmedizin Berlin, Berlin, Germany.
Kurth F; Charité - Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; I. Department of Medicine, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.
Schultze JL; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Germany; PRECISE Platform for Genomics and Epigenomics at Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), and University of Bonn, Bonn, Germany.
Radbruch H; Charité - Universitätsmedizin Berlin, Department of Neuropathology, Berlin, Germany.
Ochs M; Core Facility Electron Microscopy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; German Center for Lung Research (DZL), Germany; Institute of Functional Anatomy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Eils R; Center for Digital Health, Berlin Institute of Health (BIH) and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Müller-Redetzky H; Charité - Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany.
Hauser AE; Charité - Universitätsmedizin Berlin, Department of Rheumatology and Clinical Immunology, Charité; Deutsches Rheumaforschungszentrum, Immunodynamics, a Leibniz Institute, Berlin, Germany.
Luecken MD; Institute of Computational Biology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Theis FJ; Institute of Computational Biology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany; Department of Mathematics, Technische Universität München, Garching bei München, Germany.
Conrad C; Center for Digital Health, Berlin Institute of Health (BIH) and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Wolff T; Unit 17 Influenza and other Respiratory Viruses, Robert Koch Institute, Berlin, Germany.
Boor P; Institute of Pathology, RWTH Aachen University Hospital, Aachen, Germany.
Selbach M; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Proteome Dynamics, Berlin, Germany; Charité-Universitätsmedizin Berlin, Berlin, Germany.
Saliba AE; Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz-Center for Infection Research (HZI), Würzburg, Germany. Electronic address: .
Sander LE; Charité - Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany; German Center for Lung Research (DZL), Germany. Electronic address: .
Pokaż więcej
Corporate Authors :
Deutsche COVID-19 OMICS Initiative (DeCOI)
Źródło :
Cell [Cell] 2021 Dec 22; Vol. 184 (26), pp. 6243-6261.e27. Date of Electronic Publication: 2021 Nov 27.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19/*pathology
COVID-19/*virology
Idiopathic Pulmonary Fibrosis/*pathology
Idiopathic Pulmonary Fibrosis/*virology
Macrophages/*pathology
Macrophages/*virology
SARS-CoV-2/*physiology
Antigens, CD/metabolism ; Antigens, Differentiation, Myelomonocytic/metabolism ; COVID-19/diagnostic imaging ; Cell Communication ; Cohort Studies ; Fibroblasts/pathology ; Gene Expression Regulation ; Humans ; Idiopathic Pulmonary Fibrosis/diagnostic imaging ; Idiopathic Pulmonary Fibrosis/genetics ; Mesenchymal Stem Cells/pathology ; Phenotype ; Proteome/metabolism ; Receptors, Cell Surface/metabolism ; Respiratory Distress Syndrome/diagnostic imaging ; Respiratory Distress Syndrome/pathology ; Respiratory Distress Syndrome/virology ; Tomography, X-Ray Computed ; Transcription, Genetic
Czasopismo naukowe
Tytuł :
Idiopathic pulmonary fibrosis diagnosed concomitantly with diffuse squamous cell lung cancer on surgical lung biopsy: a case report.
Autorzy :
Niel C; Department of Respiratory Medicine, CHU Rennes, Rennes 1 University, Rennes, France.
Ricordel C; Department of Respiratory Medicine, CHU Rennes, Rennes 1 University, Rennes, France. .; INSERM U1242, Chemistry Oncogenesis Stress and signaling, CLCC Eugène Marquis, Rennes, France. .
Guy T; Department of Respiratory Medicine, Centre Hospitalier Bretagne Atlantique, Vannes, France.
Kerjouan M; Department of Respiratory Medicine, CHU Rennes, Rennes 1 University, Rennes, France.
De Latour B; Department of Thoracic Surgery, CHU Rennes, Rennes 1 University, Rennes, France.
Chiforeanu D; Department of Anatomopathology, CHU Rennes, Rennes 1 University, Rennes, France.
Lederlin M; Department of Radiology, CHU Rennes, LTI, INSERM U1099, Rennes 1 University, Rennes, France.
Jouneau S; Department of Respiratory Medicine, CHU Rennes, Rennes 1 University, Rennes, France.; IRSET UMR 1085, Rennes 1 University, Rennes, France.
Pokaż więcej
Źródło :
Journal of medical case reports [J Med Case Rep] 2021 Dec 15; Vol. 15 (1), pp. 595. Date of Electronic Publication: 2021 Dec 15.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Carcinoma, Squamous Cell*/complications
Idiopathic Pulmonary Fibrosis*/complications
Idiopathic Pulmonary Fibrosis*/diagnostic imaging
Idiopathic Pulmonary Fibrosis*/drug therapy
Lung Neoplasms*
Aged ; Biopsy ; Epithelial Cells ; Female ; Humans ; Lung/diagnostic imaging
Czasopismo naukowe
Tytuł :
Conditioned medium from a human adipose-derived stem cell line ameliorates inflammation and fibrosis in a lung experimental model of idiopathic pulmonary fibrosis.
Autorzy :
Filidou E; Lab of Pharmacology, Faculty of Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
Kandilogiannakis L; Lab of Pharmacology, Faculty of Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
Tarapatzi G; Lab of Pharmacology, Faculty of Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
Su C; Tithon Biotech Inc, San Diego, CA 92127, USA.
Po ENF; Tithon Biotech Inc, San Diego, CA 92127, USA.
Paspaliaris V; Tithon Biotech Inc, San Diego, CA 92127, USA.
Kolios G; Lab of Pharmacology, Faculty of Medicine, Democritus University of Thrace, Alexandroupolis, Greece. Electronic address: .
Pokaż więcej
Źródło :
Life sciences [Life Sci] 2021 Dec 15; Vol. 287, pp. 120123. Date of Electronic Publication: 2021 Nov 06.
Typ publikacji :
Journal Article
MeSH Terms :
Culture Media, Conditioned*/pharmacology
Disease Models, Animal*
Mesenchymal Stem Cells*/metabolism
Idiopathic Pulmonary Fibrosis/*therapy
Inflammation Mediators/*antagonists & inhibitors
Pneumonia/*therapy
Adult ; Animals ; Cell Line, Transformed ; Female ; Humans ; Idiopathic Pulmonary Fibrosis/metabolism ; Idiopathic Pulmonary Fibrosis/pathology ; Inflammation Mediators/metabolism ; Male ; Mice ; Mice, Inbred C57BL ; Pneumonia/metabolism ; Pneumonia/pathology ; Rats ; Rats, Sprague-Dawley
Czasopismo naukowe
Tytuł :
Azithromycin for the Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis: A Randomized Controlled Crossover Trial.
Autorzy :
Guler SA; Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Clarenbach C; Department of Pulmonary Medicine, University Hospital of Zürich, Zürich, Switzerland.
Brutsche M; Department of Pulmonary Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland; and.
Hostettler K; Clinics of Respiratory Medicine, University Hospital of Basel, Basel, Switzerland.
Brill AK; Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Schertel A; Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Geiser TK; Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Funke-Chambour M; Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Pokaż więcej
Źródło :
Annals of the American Thoracic Society [Ann Am Thorac Soc] 2021 Dec; Vol. 18 (12), pp. 2018-2026.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Azithromycin*
Idiopathic Pulmonary Fibrosis*/complications
Idiopathic Pulmonary Fibrosis*/drug therapy
Aged ; Cough/drug therapy ; Cough/etiology ; Cross-Over Studies ; Double-Blind Method ; Female ; Humans ; Male ; Quality of Life ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Evaluation of microRNA expression in a sheep model for lung fibrosis.
Autorzy :
Perera UE; School of Veterinary Science, The University of Melbourne, Parkville, VIC, Australia. .
Derseh HB; School of Veterinary Science, The University of Melbourne, Parkville, VIC, Australia.
Dewage SNV; Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Stent A; School of Veterinary Science, The University of Melbourne, Werribee, VIC, Australia.
Wijayarathna R; Centre for Reproductive Health, Hudson Institute of Medical Research, Australia and Monash University, Clayton, VIC, Australia.
Snibson KJ; School of Veterinary Science, The University of Melbourne, Parkville, VIC, Australia. .
Pokaż więcej
Źródło :
BMC genomics [BMC Genomics] 2021 Nov 17; Vol. 22 (1), pp. 827. Date of Electronic Publication: 2021 Nov 17.
Typ publikacji :
Journal Article
MeSH Terms :
Idiopathic Pulmonary Fibrosis*/chemically induced
Idiopathic Pulmonary Fibrosis*/genetics
MicroRNAs*/genetics
Animals ; Bleomycin/toxicity ; Genetic Techniques ; Humans ; Lung ; Mice ; Sheep
Czasopismo naukowe
Tytuł :
Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development.
Autorzy :
Samarelli AV; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena and Reggio Emilia, University of Modena Reggio Emilia, 41100 Modena, Italy.
Masciale V; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Oncology Unit, University Hospital of Modena and Reggio Emilia, University of Modena and Reggio Emilia, 41100 Modena, Italy.
Aramini B; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Thoracic Surgery Unit, Department of Diagnostic and Specialty Medicine-DIMES of the Alma Mater Studiorum, University of Bologna, G.B. Morgagni-L. Pierantoni Hospital, 34 Carlo Forlanini Street, 47121 Forlì, Italy.
Coló GP; Laboratorio de Biología del Cáncer INIBIBB-UNS-CONICET-CCT, Bahía Blanca 8000, Argentina.
Tonelli R; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena and Reggio Emilia, University of Modena Reggio Emilia, 41100 Modena, Italy.; Clinical and Experimental Medicine PhD Program, University of Modena Reggio Emilia, 41100 Modena, Italy.
Marchioni A; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena and Reggio Emilia, University of Modena Reggio Emilia, 41100 Modena, Italy.
Bruzzi G; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena and Reggio Emilia, University of Modena Reggio Emilia, 41100 Modena, Italy.
Gozzi F; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena and Reggio Emilia, University of Modena Reggio Emilia, 41100 Modena, Italy.; Clinical and Experimental Medicine PhD Program, University of Modena Reggio Emilia, 41100 Modena, Italy.
Andrisani D; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena and Reggio Emilia, University of Modena Reggio Emilia, 41100 Modena, Italy.; Clinical and Experimental Medicine PhD Program, University of Modena Reggio Emilia, 41100 Modena, Italy.
Castaniere I; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena and Reggio Emilia, University of Modena Reggio Emilia, 41100 Modena, Italy.; Clinical and Experimental Medicine PhD Program, University of Modena Reggio Emilia, 41100 Modena, Italy.
Manicardi L; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena and Reggio Emilia, University of Modena Reggio Emilia, 41100 Modena, Italy.
Moretti A; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena and Reggio Emilia, University of Modena Reggio Emilia, 41100 Modena, Italy.
Tabbì L; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena and Reggio Emilia, University of Modena Reggio Emilia, 41100 Modena, Italy.
Guaitoli G; Oncology Unit, University Hospital of Modena and Reggio Emilia, University of Modena and Reggio Emilia, 41100 Modena, Italy.; Clinical and Experimental Medicine PhD Program, University of Modena Reggio Emilia, 41100 Modena, Italy.
Cerri S; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena and Reggio Emilia, University of Modena Reggio Emilia, 41100 Modena, Italy.
Dominici M; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Oncology Unit, University Hospital of Modena and Reggio Emilia, University of Modena and Reggio Emilia, 41100 Modena, Italy.
Clini E; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena and Reggio Emilia, University of Modena Reggio Emilia, 41100 Modena, Italy.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Nov 10; Vol. 22 (22). Date of Electronic Publication: 2021 Nov 10.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Idiopathic Pulmonary Fibrosis/*genetics
Lung Neoplasms/*genetics
Animals ; Humans ; Idiopathic Pulmonary Fibrosis/diagnosis ; Idiopathic Pulmonary Fibrosis/drug therapy ; Lung Neoplasms/diagnosis ; Lung Neoplasms/drug therapy ; Mechanotransduction, Cellular ; Myofibroblasts/metabolism ; Transforming Growth Factor beta1/metabolism
Czasopismo naukowe
Tytuł :
Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.
Autorzy :
Petnak T; Division of Pulmonary and Pulmonary Critical Care Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Thailand; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN.
Lertjitbanjong P; Division of Pulmonary, Critical Care, and Sleep Medicine, University of Tennessee Health Science Center, Memphis, TN.
Thongprayoon C; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN.
Moua T; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN. Electronic address: .
Pokaż więcej
Źródło :
Chest [Chest] 2021 Nov; Vol. 160 (5), pp. 1751-1763. Date of Electronic Publication: 2021 Jul 02.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Idiopathic Pulmonary Fibrosis*/drug therapy
Idiopathic Pulmonary Fibrosis*/mortality
Idiopathic Pulmonary Fibrosis*/physiopathology
Indoles/*pharmacology
Pyridones/*pharmacology
Antifibrotic Agents/pharmacology ; Humans ; Mortality ; Symptom Flare Up ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Essential role of IL-23 in the development of acute exacerbation of pulmonary fibrosis.
Autorzy :
Senoo S; Department of Hematology, Oncology, Allergy and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
Taniguchi A; Department of Hematology, Oncology, Allergy and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
Itano J; Department of Hematology, Oncology, Allergy and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
Oda N; Department of Hematology, Oncology, Allergy and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
Morichika D; Department of Hematology, Oncology, Allergy and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
Fujii U; Department of Hematology, Oncology, Allergy and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
Guo L; Department of Medical Technology, Okayama University Graduate School of Health Sciences, Okayama, Japan.
Sunami R; Department of Hematology, Oncology, Allergy and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
Kanehiro A; Department of Hematology, Oncology, Allergy and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
Tokioka F; Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, Japan.
Yoshimura A; Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.
Kiura K; Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
Maeda Y; Department of Hematology, Oncology, Allergy and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
Miyahara N; Department of Medical Technology, Okayama University Graduate School of Health Sciences, Okayama, Japan.; Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
Pokaż więcej
Źródło :
American journal of physiology. Lung cellular and molecular physiology [Am J Physiol Lung Cell Mol Physiol] 2021 Nov 01; Vol. 321 (5), pp. L925-L940. Date of Electronic Publication: 2021 Sep 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Idiopathic Pulmonary Fibrosis/*etiology
Idiopathic Pulmonary Fibrosis/*immunology
Inflammation/*metabolism
Interleukin-23/*metabolism
Acute Disease ; Animals ; Idiopathic Pulmonary Fibrosis/metabolism ; Inflammation/pathology ; Interleukin-17/immunology ; Interleukin-17/metabolism ; Interleukin-23/immunology ; Interleukins/immunology ; Interleukins/metabolism ; Lung/immunology ; Lung/pathology ; Mice ; Th17 Cells/immunology ; Th17 Cells/metabolism
Czasopismo naukowe
Tytuł :
Managing Cough in Idiopathic Pulmonary Fibrosis.
Autorzy :
Wakwaya Y; Pulmonary and Critical Care Medicine, Baylor University Medical Center, Dallas, TX.
Ramdurai D; University of Pennsylvania, Philadelphia, PA.
Swigris JJ; Division of Pulmonary, Critical Care and Sleep Medicine, Interstitial Lung Disease Program, National Jewish Health, Denver, CO. Electronic address: .
Pokaż więcej
Źródło :
Chest [Chest] 2021 Nov; Vol. 160 (5), pp. 1774-1782. Date of Electronic Publication: 2021 Jun 23.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Cough*/etiology
Cough*/physiopathology
Cough*/psychology
Cough*/therapy
Idiopathic Pulmonary Fibrosis*/epidemiology
Idiopathic Pulmonary Fibrosis*/physiopathology
Quality of Life*
Gastroesophageal Reflux/epidemiology ; Gastroesophageal Reflux/physiopathology ; Humans ; Patient Care Management/methods
Czasopismo naukowe
Tytuł :
Successful Treatment with High-dose Steroids for Acute Exacerbation of Idiopathic Pulmonary Fibrosis Triggered by COVID-19.
Autorzy :
Omote N; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Japan.; Department of Internal Medicine, Aichi Prefectural Hospital, Japan.
Kanemitsu Y; Department of Internal Medicine, Aichi Prefectural Hospital, Japan.; Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Japan.
Inoue T; Department of Internal Medicine, Aichi Prefectural Hospital, Japan.; Department of Respiratory Medicine, Fujita Health University School of Medicine, Japan.
Yonezawa T; Department of Internal Medicine, Aichi Prefectural Hospital, Japan.; Department of Respiratory Medicine and Allergology, Aichi Medical University, Japan.
Ichihashi T; Department of Internal Medicine, Aichi Prefectural Hospital, Japan.
Shindo Y; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Japan.; Department of Internal Medicine, Aichi Prefectural Hospital, Japan.
Sakamoto K; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Japan.
Ando A; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Japan.
Suzuki A; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Japan.
Niimi A; Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Japan.
Ito S; Department of Respiratory Medicine and Allergology, Aichi Medical University, Japan.
Imaizumi K; Department of Respiratory Medicine, Fujita Health University School of Medicine, Japan.
Hashimoto N; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Japan.
Pokaż więcej
Źródło :
Internal medicine (Tokyo, Japan) [Intern Med] 2022 Jan 15; Vol. 61 (2), pp. 233-236. Date of Electronic Publication: 2021 Nov 06.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
COVID-19*
Idiopathic Pulmonary Fibrosis*/drug therapy
Aged, 80 and over ; Disease Progression ; Female ; Humans ; SARS-CoV-2 ; Steroids
Czasopismo naukowe
Tytuł :
[Update in interstitial lung disease 2021].
Autorzy :
Huang H; Department of Respiratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Pokaż więcej
Źródło :
Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases [Zhonghua Jie He He Hu Xi Za Zhi] 2022 Jan 12; Vol. 45 (1), pp. 95-99.
Typ publikacji :
Journal Article
MeSH Terms :
Alveolitis, Extrinsic Allergic*/diagnosis
Alveolitis, Extrinsic Allergic*/drug therapy
Idiopathic Pulmonary Fibrosis*/diagnosis
Idiopathic Pulmonary Fibrosis*/drug therapy
Lung Diseases, Interstitial*/diagnosis
Lung Diseases, Interstitial*/drug therapy
Disease Progression ; Humans
Czasopismo naukowe
Tytuł :
Acute worsening of native lung fibrosis after single lung transplantation for pulmonary fibrosis: two case reports.
Autorzy :
Goletto T; Service de Pneumologie B, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, 75018, Paris, France.; Inserm UMR1152, Université Paris7 Denis Diderot, 75018, Paris, France.
Decaux S; Service de Pneumologie B, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, 75018, Paris, France.; Inserm UMR1152, Université Paris7 Denis Diderot, 75018, Paris, France.
Bunel V; Service de Pneumologie B, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, 75018, Paris, France.; Inserm UMR1152, Université Paris7 Denis Diderot, 75018, Paris, France.
Weisenburger G; Service de Pneumologie B, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, 75018, Paris, France.; Inserm UMR1152, Université Paris7 Denis Diderot, 75018, Paris, France.
Messika J; Service de Pneumologie B, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, 75018, Paris, France.; Inserm UMR1152, Université Paris7 Denis Diderot, 75018, Paris, France.
Najem S; Service de Pneumologie B, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, 75018, Paris, France.; Inserm UMR1152, Université Paris7 Denis Diderot, 75018, Paris, France.
Medraoui C; Service de Pneumologie B, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, 75018, Paris, France.; Inserm UMR1152, Université Paris7 Denis Diderot, 75018, Paris, France.
Godet C; Service de Pneumologie B, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, 75018, Paris, France.; Inserm UMR1152, Université Paris7 Denis Diderot, 75018, Paris, France.
Debray MP; Service de Radiologie, Hôpital Bichat, Paris, France.
Lortat-Jacob B; Service de Réanimation Chirurgicale, Hôpital Bichat, Paris, France.
Mordant P; Service de Chirurgie Vasculaire, Thoracique et Transplantation Pulmonaire, Hôpital Bichat, Paris, France.
Castier Y; Service de Chirurgie Vasculaire, Thoracique et Transplantation Pulmonaire, Hôpital Bichat, Paris, France.
Bouadma L; Service de Réanimation Médicale et Infectieuse, Hôpital Bichat, Paris, France.
Borie R; Service de Pneumologie A, Hôpital Bichat, Paris, France.
Mal H; Service de Pneumologie B, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, 75018, Paris, France. .; Inserm UMR1152, Université Paris7 Denis Diderot, 75018, Paris, France. .; Service de Pneumologie B et Transplantation Pulmonaire, Hôpital Bichat, 46 rue Henri Huchard, 75018, Paris, France. .
Pokaż więcej
Źródło :
Journal of medical case reports [J Med Case Rep] 2022 Jan 03; Vol. 16 (1), pp. 2. Date of Electronic Publication: 2022 Jan 03.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
COVID-19*
Idiopathic Pulmonary Fibrosis*/therapy
Lung Transplantation*
Humans ; Lung ; Male ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
The prognostic value of the COPD Assessment Test in fibrotic interstitial lung disease.
Autorzy :
Matsuda T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan.
Kondoh Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan. Electronic address: .
Furukawa T; Department of Medical IT Center, Nagoya University Hospital, Nagoya, Aichi, Japan.
Suzuki A; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Takei R; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan.
Sasano H; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan.
Yamano Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan.
Yokoyama T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan.
Kataoka K; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan.
Kimura T; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan.
Pokaż więcej
Źródło :
Respiratory investigation [Respir Investig] 2022 Jan; Vol. 60 (1), pp. 99-107. Date of Electronic Publication: 2021 Sep 20.
Typ publikacji :
Journal Article
MeSH Terms :
Idiopathic Pulmonary Fibrosis*/diagnosis
Lung Diseases, Interstitial*/diagnosis
Pulmonary Disease, Chronic Obstructive*/diagnosis
Humans ; Lung/diagnostic imaging ; Male ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Vardenafil Activity in Lung Fibrosis and In Vitro Synergy with Nintedanib.
Autorzy :
Bourne MH Jr; Thoracic Diseases Research Unit, Departments of Medicine and Biochemistry, 8-24 Stabile, Mayo Clinic, Rochester, MN 55905, USA.
Kottom TJ; Thoracic Diseases Research Unit, Departments of Medicine and Biochemistry, 8-24 Stabile, Mayo Clinic, Rochester, MN 55905, USA.
Hebrink DM; Thoracic Diseases Research Unit, Departments of Medicine and Biochemistry, 8-24 Stabile, Mayo Clinic, Rochester, MN 55905, USA.
Choudhury M; Thoracic Diseases Research Unit, Departments of Medicine and Biochemistry, 8-24 Stabile, Mayo Clinic, Rochester, MN 55905, USA.
Leof EB; Thoracic Diseases Research Unit, Departments of Medicine and Biochemistry, 8-24 Stabile, Mayo Clinic, Rochester, MN 55905, USA.
Limper AH; Thoracic Diseases Research Unit, Departments of Medicine and Biochemistry, 8-24 Stabile, Mayo Clinic, Rochester, MN 55905, USA.
Pokaż więcej
Źródło :
Cells [Cells] 2021 Dec 11; Vol. 10 (12). Date of Electronic Publication: 2021 Dec 11.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Idiopathic Pulmonary Fibrosis/*drug therapy
Indoles/*therapeutic use
Vardenafil Dihydrochloride/*therapeutic use
Animals ; Bleomycin ; Cell Proliferation/drug effects ; Cells, Cultured ; Collagen Type I/metabolism ; Disease Models, Animal ; Drug Synergism ; Extracellular Matrix/drug effects ; Extracellular Matrix/metabolism ; Female ; Fibroblasts/drug effects ; Fibroblasts/metabolism ; Fibronectins/metabolism ; Gene Expression Regulation/drug effects ; Humans ; Idiopathic Pulmonary Fibrosis/genetics ; Idiopathic Pulmonary Fibrosis/pathology ; Indoles/pharmacology ; Lung/pathology ; Mechanistic Target of Rapamycin Complex 1/metabolism ; Mechanistic Target of Rapamycin Complex 2/metabolism ; Mice, Inbred C57BL ; Phosphorylation/drug effects ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Signal Transduction/drug effects ; Smad2 Protein/metabolism ; Smad3 Protein/metabolism ; Survival Analysis ; Transforming Growth Factor beta1/metabolism ; Vardenafil Dihydrochloride/pharmacology
Czasopismo naukowe
Tytuł :
Patterns of Carbon-Bound Exogenous Compounds in Patients with Lung Cancer and Association with Disease Pathophysiology.
Autorzy :
Kunzke T; Research Unit Analytical Pathology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Prade VM; Research Unit Analytical Pathology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Buck A; Research Unit Analytical Pathology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Sun N; Research Unit Analytical Pathology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Feuchtinger A; Research Unit Analytical Pathology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Matzka M; Research Unit Analytical Pathology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Fernandez IE; Department of Internal Medicine V, Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Ludwig-Maximilians-Universität München, Munich, Germany.; Institute of Lung Biology and Disease, Comprehensive Pneumology Center, Helmholtz Zentrum München, Member of the German Center for Lung Research (DZL), Munich, Germany.
Wuyts W; Department of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.
Ackermann M; Institute of Functional and Clinical Anatomy, University Medical Center Mainz, Johannes Gutenberg-University Mainz, Mainz, Germany.; Institute of Pathology and Molecular Pathology, Helios University Hospital Wuppertal, University of Witten/Herdecke, Wuppertal, Germany.
Jonigk D; Institute of Pathology, Hannover Medical School, Hannover, Germany. Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH).; German Center for Lung Research (DZL), Hannover Medical School, Hannover, Germany.
Aichler M; Research Unit Analytical Pathology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Schmid RA; Department of General Thoracic Surgery, Inselspital University Hospital Bern, Bern, Switzerland.
Eickelberg O; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Berezowska S; Institute of Pathology, University of Bern, Bern, Switzerland. .; Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Walch A; Research Unit Analytical Pathology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany. .
Pokaż więcej
Źródło :
Cancer research [Cancer Res] 2021 Dec 01; Vol. 81 (23), pp. 5862-5875. Date of Electronic Publication: 2021 Oct 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Metabolome*
Tumor Microenvironment*
Carcinoma, Squamous Cell/*pathology
Idiopathic Pulmonary Fibrosis/*pathology
Lung Neoplasms/*pathology
Nitrosamines/*adverse effects
Polycyclic Aromatic Hydrocarbons/*adverse effects
Carcinogenesis ; Carcinoma, Squamous Cell/chemically induced ; Carcinoma, Squamous Cell/metabolism ; Humans ; Idiopathic Pulmonary Fibrosis/chemically induced ; Idiopathic Pulmonary Fibrosis/metabolism ; Lung Neoplasms/chemically induced ; Lung Neoplasms/metabolism ; Mass Spectrometry ; Retrospective Studies ; Tobacco Use
Czasopismo naukowe
Tytuł :
[Epidemiology of fibrosing interstitial lung diseases in the department of Haute Garonne].
Autorzy :
Villeneuve T; Service de pneumologie, Hôpital Larrey, Université Paul Sabatier, CHU Toulouse, Toulouse, France. Electronic address: .
Prévot G; Service de pneumologie, Hôpital Larrey, Université Paul Sabatier, CHU Toulouse, Toulouse, France.
Lintz F; Service de pneumologie, clinique Pasteur, Toulouse, France.
Mourin G; Service de pneumologie, clinique d'Occitanie, Muret, France.
Ferry G; Service de pneumologie, clinique des Cèdres, Cornebarrieu, France.
Bousquet E; Service de pneumologie, clinique L'Union, Saint-Jean, France.
Perelroizen H; Service de pneumologie, clinique La Croix du Sud, Quint-Fonsegrives, France.
Boghanim T; Service de pneumologie, Hôpital Larrey, Université Paul Sabatier, CHU Toulouse, Toulouse, France.
Faviez G; Service de pneumologie, Hôpital Larrey, Université Paul Sabatier, CHU Toulouse, Toulouse, France.
Noël-Savina E; Service de pneumologie, Hôpital Larrey, Université Paul Sabatier, CHU Toulouse, Toulouse, France.
Collot S; Service de radiologie, Hôpital Larrey-Rangueil, Université Paul-Sabatier, CHU Toulouse, Toulouse, France.
Le Borgne A; Service de pneumologie, Hôpital Larrey, Université Paul Sabatier, CHU Toulouse, Toulouse, France.
Didier A; Service de pneumologie, Hôpital Larrey, Université Paul Sabatier, CHU Toulouse, Toulouse, France.
Pokaż więcej
Transliterated Title :
EPIDemio : épidémiologie des pneumopathies interstitielles diffuses (PID) fibrosantes en Haute-Garonne.
Źródło :
Revue des maladies respiratoires [Rev Mal Respir] 2021 Dec; Vol. 38 (10), pp. 972-979. Date of Electronic Publication: 2021 Oct 08.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Idiopathic Pulmonary Fibrosis*/diagnosis
Idiopathic Pulmonary Fibrosis*/epidemiology
Lung Diseases, Interstitial*/diagnosis
Lung Diseases, Interstitial*/epidemiology
Disease Progression ; Fibrosis ; Humans ; Prospective Studies
Czasopismo naukowe
Tytuł :
Physical activity decline is disproportionate to decline in pulmonary physiology in IPF.
Autorzy :
Prasad JD; Lung Fibrosis Service, Department of General Respiratory Medicine and Lung Transplantation, Alfred Hospital, Melbourne, Victoria, Australia.; Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Paul E; Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Holland AE; Central Clinical School, Monash University, Melbourne, Victoria, Australia.; Physiotherapy Department, Alfred Hospital, Melbourne, Victoria, Australia.; Institute for Breathing and Sleep, Melbourne, Victoria, Australia.
Glaspole IN; Lung Fibrosis Service, Department of General Respiratory Medicine and Lung Transplantation, Alfred Hospital, Melbourne, Victoria, Australia.; Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Westall GP; Lung Fibrosis Service, Department of General Respiratory Medicine and Lung Transplantation, Alfred Hospital, Melbourne, Victoria, Australia.; Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Pokaż więcej
Źródło :
Respirology (Carlton, Vic.) [Respirology] 2021 Dec; Vol. 26 (12), pp. 1152-1159. Date of Electronic Publication: 2021 Aug 26.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Idiopathic Pulmonary Fibrosis*
Exercise ; Humans ; Lung ; Quality of Life ; Vital Capacity
Czasopismo naukowe
Tytuł :
Interstitial Lung Disease in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Patients: Comparison With Idiopathic Pulmonary Fibrosis.
Autorzy :
Kwon M; From the Division of Pulmonary, Allergy, and Sleep Medicine.
Lee AS; From the Division of Pulmonary, Allergy, and Sleep Medicine.
Mira-Avendano I; From the Division of Pulmonary, Allergy, and Sleep Medicine.
Rojas CA; Division of Thoracic/Cardiac Radiology.
Grage R; Division of Thoracic/Cardiac Radiology.
Abril A; Division of Rheumatology, Mayo Clinic, Jacksonville, FL.
Pokaż więcej
Źródło :
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases [J Clin Rheumatol] 2021 Dec 01; Vol. 27 (8), pp. 324-330.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/complications
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/diagnosis
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/therapy
Churg-Strauss Syndrome*
Granulomatosis with Polyangiitis*
Idiopathic Pulmonary Fibrosis*/diagnosis
Idiopathic Pulmonary Fibrosis*/therapy
Lung Diseases, Interstitial*/diagnosis
Lung Diseases, Interstitial*/etiology
Lung Diseases, Interstitial*/therapy
Antibodies, Antineutrophil Cytoplasmic ; Humans ; Lung ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Recent trends in pirfenidone and nintedanib use for idiopathic pulmonary fibrosis in Australia.
Autorzy :
Cox IA; Menzies Institute for Medical Research, The University of Tasmania, Hobart, Tas., Australia. Email: ; ; ; and National Health and Medical Research Council (NHMRC) Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, NSW, Australia. Email: ; ; .
de Graaff B; Menzies Institute for Medical Research, The University of Tasmania, Hobart, Tas., Australia. Email: ; ; ; and National Health and Medical Research Council (NHMRC) Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, NSW, Australia. Email: ; ; .
Corte TJ; National Health and Medical Research Council (NHMRC) Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, NSW, Australia. Email: ; ; ; and Central Clinical School, The University of Sydney, Camperdown, NSW, Australia; and Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
Glaspole I; National Health and Medical Research Council (NHMRC) Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, NSW, Australia. Email: ; ; ; and Interstitial Lung Disease Clinic, Alfred Hospital, Melbourne, Vic., Australia; and Central Clinical School, Monash University, Melbourne, Vic., Australia.
Chambers DC; National Health and Medical Research Council (NHMRC) Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, NSW, Australia. Email: ; ; ; and School of Clinical Medicine, The University of Queensland, Brisbane, Qld, Australia. Email: ; and Queensland Lung Transplant Service, The Prince Charles Hospital, Brisbane, Qld, Australia.
Moodley Y; National Health and Medical Research Council (NHMRC) Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, NSW, Australia. Email: ; ; ; and Faculty of Health and Medical Sciences, The University of Western Australia, Perth, WA, Australia. Email: ; and Institute of Respiratory Health, The University of Western Australia, Perth, WA, Australia; and Department of Respiratory Medicine, Fiona Stanley Hospital, Murdoch, WA, Australia.
Teoh A; National Health and Medical Research Council (NHMRC) Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, NSW, Australia. Email: ; ; ; and Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
Walters EH; Menzies Institute for Medical Research, The University of Tasmania, Hobart, Tas., Australia. Email: ; ; ; and National Health and Medical Research Council (NHMRC) Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, NSW, Australia. Email: ; ; .
Palmer AJ; Menzies Institute for Medical Research, The University of Tasmania, Hobart, Tas., Australia. Email: ; ; ; and National Health and Medical Research Council (NHMRC) Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, NSW, Australia. Email: ; ; ; and Centre for Health Policy, School of Population and Global Health, The University of Melbourne, Melbourne, Vic., Australia; and Corresponding author. Email: .
Pokaż więcej
Źródło :
Australian health review : a publication of the Australian Hospital Association [Aust Health Rev] 2021 Dec; Vol. 45 (6), pp. 718-727.
Typ publikacji :
Journal Article
MeSH Terms :
Idiopathic Pulmonary Fibrosis*/drug therapy
Idiopathic Pulmonary Fibrosis*/epidemiology
Australia/epidemiology ; Humans ; Indoles ; Pyridones ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Deleterious Role of Th9 Cells in Pulmonary Fibrosis.
Autorzy :
Deng KM; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510182, China.
Yang XS; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510182, China.
Luo Q; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510182, China.
She YX; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510182, China.
Yu QY; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510182, China.
Tang XX; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510182, China.
Pokaż więcej
Źródło :
Cells [Cells] 2021 Nov 17; Vol. 10 (11). Date of Electronic Publication: 2021 Nov 17.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Idiopathic Pulmonary Fibrosis/*immunology
T-Lymphocytes, Helper-Inducer/*immunology
Animals ; Antibodies, Neutralizing/metabolism ; Bleomycin ; Case-Control Studies ; Cell Differentiation ; Cell Proliferation ; Collagen/metabolism ; Female ; Fibroblasts/pathology ; Humans ; Idiopathic Pulmonary Fibrosis/pathology ; Interleukin-9/metabolism ; Leukocytes, Mononuclear/metabolism ; Lung/immunology ; Lung/pathology ; Lymphocyte Activation/immunology ; Male ; Middle Aged ; Proteomics ; Signal Transduction
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies